Patents
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
08/1995
08/17/1995WO1995007994A3 Recombinant alphavirus vectors
08/17/1995CA2183260A1 Prolactin as a vaccine adjuvant
08/17/1995CA2182978A1 Peptides and methods against diabetes
08/17/1995CA2182969A1 Methods for identifying individuals suffering from a cellular abnormality
08/17/1995CA2182118A1 Nucleic acid-containing composition, its preparation and use
08/16/1995EP0666929A1 Method of inhibiting replication of hyperproliferative cells
08/16/1995EP0666923A1 Targeted delivery of poly- or oligonucleotides to cells
08/16/1995EP0666914A1 Novel p-selectin ligand protein
08/16/1995EP0666911A1 Multidrug resistance gene
08/16/1995EP0666745A1 Diagnosis and therapy for parkinson's disease
08/16/1995EP0532525B1 New protein-polycation conjugates
08/15/1995US5441875 Urea transporter polypeptide
08/15/1995US5441739 Reduced and controlled surface binding of biologically active molecules
08/15/1995CA1336678C Prophylaxis and treatment of nervous system diseases with melanin
08/10/1995WO1995021380A1 Assay for screening of receptor antagonists
08/10/1995WO1995021259A1 Adenoviral-mediated method of cell transfection
08/10/1995WO1995021253A1 Ets1 gene: a human tumor suppressor gene
08/10/1995WO1995021245A1 Nucleic acid encoding neuropeptide y/peptide yy (y2) receptors and uses thereof
08/10/1995WO1995021195A1 Non-viral vector
08/10/1995WO1995021184A1 Substituted purines and oligonucleotide cross-linking
08/10/1995WO1995021179A1 Endotoxin reduction or removal process
08/10/1995WO1995021178A1 Nucleic acid transfection efficiency increase by use of isopropanol in aqueous solutions
08/10/1995WO1995021177A1 Process for producing endotoxin-free or endotoxin-poor nucleic acids and/or oligonucleotides for gene therapy
08/10/1995WO1995015373A3 Inhibition of dna methyltransferase
08/10/1995CA2182616A1 Non-viral vector
08/10/1995CA2159217A1 Nucleic acid encoding neuropeptide y/peptide yy (y2) receptors and uses thereof
08/09/1995EP0666313A2 Targeting of telomerase in cancer gene therapy
08/09/1995EP0665885A1 Polypeptides (5ht2c) having a serotoninergic receptor activity and uses thereof
08/09/1995EP0665739A1 Morphogen-induced periodontal tissue regeneration
08/03/1995WO1995020678A1 Human dna mismatch repair proteins
08/03/1995WO1995020660A2 Immunization by inoculation of dna transcription unit
08/03/1995WO1995020656A1 Diagnosis of metastatic cancer by the mts-1 gene
08/03/1995WO1995020404A1 Triplex-forming paired-ion oligonucleotides and methods for preparing and using same
08/03/1995WO1995020398A1 Human growth hormone
08/03/1995WO1995012660A3 Recombinant p53 adenovirus methods and compositions
08/03/1995CA2182206A1 Human dna mismatch repair proteins
08/03/1995CA2182205A1 Human growth hormone
08/03/1995CA2181062A1 Diagnosis of metastatic cancer by the mts-1 gene
08/02/1995EP0664832A1 Remyelination using neural stem cells
08/01/1995US5437994 Method for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells
07/1995
07/27/1995WO1995020042A1 Embryonic stem cell isolation
07/27/1995WO1995019985A1 Haemopoietic maturation factor
07/27/1995WO1995019799A1 Gas driven gene delivery instrument
07/27/1995WO1995019793A1 Hematopoietic cell expansion and transplantation methods
07/27/1995WO1995019785A1 Treatment for juvenile diabetes
07/27/1995WO1995019769A1 Combinations of a creatine compound with a hyperplastic inhibitory agent for inhibiting undesirable cell growth
07/27/1995CA2181547A1 Hematopoietic cell expansion and transplantation methods
07/27/1995CA2181431A1 Haemopoietic maturation factor
07/25/1995US5435999 Cytokines for cell proliferation
07/20/1995WO1995019448A1 Nucleic acid mutation detection in histologic tissue
07/20/1995WO1995019434A1 Tissue-specific enhancer active in prostate
07/20/1995WO1995019433A2 Anti-hepatitis b poly- and oligonucleotides
07/20/1995WO1995019431A1 Zinc finger protein derivatives and methods therefor
07/20/1995WO1995019429A2 Method and reagent for inhibiting hepatitis c virus replication
07/20/1995WO1995019375A1 Peptides and methods against psoriasis
07/20/1995WO1995019183A1 Cd44 expression in smooth muscle cells
07/20/1995WO1995019182A1 Somatic gene therapy to cells associated with fluid spaces
07/20/1995WO1995019167A1 Therapeutic treatment for inhibiting vascular restenosis
07/20/1995WO1995007995A3 Adeno-associated viral (aav) liposomes and methods related thereto
07/20/1995CA2210396A1 Method for detection and treatment of breast cancer
07/20/1995CA2181170A1 Somatic gene therapy to cells associated with fluid spaces
07/20/1995CA2181147A1 Nucleic acid mutation detection in histologic tissue
07/20/1995CA2181035A1 Therapeutic treatment for inhibiting vascular restenosis
07/20/1995CA2180740A1 Method and reagent for inhibiting hepatitis c virus replication
07/20/1995CA2180347A1 Anti-hepatitis b poly- and oligonucleotides
07/20/1995CA2179391A1 Cd44 expression in smooth muscle cells
07/20/1995CA2179280A1 Peptides and methods against psoriasis
07/19/1995EP0663013A1 Method for delivering nucleic acids into cells
07/19/1995EP0663008A1 Improvements in or relating to immune response modification
07/19/1995EP0662976A1 Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity
07/19/1995EP0662837A1 Use of il-10 to prevent or treat insulin-dependent diabetes mellitus
07/19/1995EP0662827A1 Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids
07/18/1995US5434086 Method of testing potential cystic fibrosis treating compounds using cells in culture
07/18/1995US5433946 Synthesis and utilization of therapeutic agents for the treatment of lysosomal storage diseases
07/13/1995WO1995018863A1 Composition containing nucleic acids, preparation and uses
07/13/1995WO1995018860A1 Control of marek's disease by the inhibition of latency and tumor cell development
07/13/1995WO1995018856A1 Vertebrate embryonic pattern-inducing hedgehog-like proteins
07/13/1995WO1995018854A1 Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs
07/13/1995WO1995018824A1 ISOLATED p27 PROTEIN AND ITS ENCODING NUCLEIC ACID MOLECULES
07/13/1995WO1995018819A1 Ligand that binds fas antigen
07/13/1995WO1995008631A3 Target antigens of transmission blocking antibodies for malaria parasites
07/13/1995CA2180358A1 Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs
07/12/1995EP0662150A1 Maspin, a novel serpin with tumor suppressing activity
07/12/1995EP0662140A1 Method of enhancing and/or prolonging expression of a gene introduced into a cell
07/12/1995EP0662137A1 Gene transcription and ionizing radiation: methods and compositions
07/12/1995EP0662128A1 Methods and compositions for controlling translation of hcv proteins
07/12/1995EP0662077A1 Cd27 ligand
07/12/1995EP0662003A1 Oligonucleotide modulation of cell adhesion
07/12/1995EP0661987A1 Morphogen-induced liver regeneration
07/12/1995EP0661979A1 Cross-linking oligonucleotides for enzyme-mediated triple strand formation
07/12/1995EP0661933A1 Morphogen-enriched dietary composition
07/11/1995CA1336269C Expression of mammalian genes at high levels in host cells
07/06/1995WO1995018226A1 Tuberous sclerosis 2 gene and uses thereof
07/06/1995WO1995018225A1 Polycystic kidney disease 1 gene and uses thereof
07/06/1995WO1995018223A1 Gene expression control
07/06/1995WO1995018221A1 Gene coding for adseverins
07/06/1995WO1995017906A1 Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof
07/06/1995WO1995017905A1 Ileal bile acid transporter compositions and methods
07/06/1995WO1995017903A1 Modular design and synthesis of oxazolone-derived molecules
07/06/1995WO1995011984A3 Recombinant adenoviral vector and methods of use